LifeStance Health Group, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $23.6M | $14.2M | $1.1M | $-3.8M | $709.0K | $709.0K | $-23.3M | $-21.1M |
| Depreciation & Amortization | $11.3M | $10.4M | $10.3M | $10.6M | $10.3M | $10.4M | $10.1M | $10.0M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $2.9M | $3.0M | $3.2M | $3.4M | $3.5M | $4.7M | $8.5M | $12.5M |
| Stock-Based Compensation | — | $15.2M | — | — | $18.6M | — | — | $20.6M |
| Net Cash from Operating Activities | $99.9M | $33.1M | $27.3M | $64.4M | $-3.1M | $22.7M | $44.1M | $-21.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $12.0M | $10.8M | $10.3M | $7.8M | $7.2M | $5.1M | $5.1M | $5.1M |
| Business Acquisitions | — | $3.1M | — | — | $0 | — | — | $0 |
| Net Cash from Investing Activities | — | $-13.9M | — | — | $-7.2M | — | — | $-5.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | $49.1M | — | — | $0 | — | — | — |
| Net Cash from Financing Activities | — | $-73.0M | — | — | $-10.0M | — | — | $-2.4M |
| Net Change in Cash | — | $-53.8M | — | — | $-20.2M | — | — | $-29.4M |
| Free Cash Flow | $87.9M | $22.3M | $17.0M | $56.6M | $-10.3M | $17.7M | $39.0M | $-26.9M |